J&J Stock Trading Above 200 & 50 Day SMA for 2 Months: Time to Buy?

Key Takeaways Johnson & Johnson stock has traded above its 50- and 200-day SMAs since mid-June.J&J posted strong Q2 results, raised guidance and achieved a bullish golden cross in July.Diversified operations and new drugs support growth despite Stelara losses and China headwinds.Johnson & Johnson’s (JNJ) stock has been trading above its 50-day and 200-day simple moving averages (SMAs) since mid-June. It achieved the golden cross in mid-July, after the company announced strong second-quarter 2025 results and ...